Parke Bancorp, Inc. — Q1 2023 Form 10-Q Summary
Business Context and Reporting Period
Parke Bancorp, Inc. is a New Jersey-based bank holding company operating through Parke Bank, which provides commercial and retail banking services primarily in southern New Jersey and the Philadelphia area. The report covers the three months ended March 31, 2023. The interim financial statements are unaudited.
Key Financial Metrics
| Metric | Q1 2023 | Comparable period or prior period |
|---|---|---|
| Net income available to common shareholders | $11.1 million | $10.1 million in Q1 2022 |
| Basic/diluted EPS | $0.93/$0.92 | $0.85/$0.83 in Q1 2022 |
| Net interest income | $17.1 million | $17.1 million in Q1 2022 |
| Net interest margin | 3.65% | 3.41% in Q1 2022 |
| Total assets | $1.96 billion | $1.98 billion at December 31, 2022 |
| Total loans | $1.76 billion | $1.75 billion at December 31, 2022 |
| Allowance for credit losses on loans | $31.5 million, or 1.79% of loans | $31.8 million, or 1.82%, at December 31, 2022 |
| Total deposits | $1.46 billion | $1.58 billion at December 31, 2022 |
| FHLBNY borrowings | $165.2 million | $83.2 million at December 31, 2022 |
| Total shareholders’ equity | $273.1 million | $266.0 million at December 31, 2022 |
| Cash and cash equivalents | $146.0 million | $182.2 million at December 31, 2022 |
| Net cash provided by operating activities | $10.5 million | $8.7 million in Q1 2022 |
Total interest income increased to $26.0 million from $19.6 million, but interest expense increased to $8.9 million from $2.5 million as deposit and borrowing costs rose. The effective tax rate was 23.6%, compared with 25.2% in Q1 2022.
Material Changes Versus Comparable Period and Prior Quarter-End
- Net income available to common shareholders increased 10.3%, primarily because of a $2.4 million recovery of credit losses, partly offset by lower non-interest income and higher operating expenses.
- Net interest income was essentially unchanged because higher loan yields and balances were offset by substantially higher deposit and borrowing costs.
- Non-interest income declined $293,000 to $1.8 million, primarily because of lower deposit service fees and loan fees.
- Non-interest expense increased $1.1 million to $6.8 million, driven mainly by higher compensation and benefits and higher other-real-estate-owned expenses.
- Loans increased $11.2 million, or 0.6%, with growth in commercial owner-occupied and residential loans partly offset by a $23.0 million decline in construction loans.
- Deposits declined $112.2 million, or 7.1%, including a $75.4 million decrease in noninterest-bearing deposits. Cannabis-related deposits declined to approximately $122.8 million from $176.6 million at year-end.
- FHLBNY borrowings increased $82.0 million, partially offsetting deposit outflows. The Company reported $517.1 million of remaining FHLBNY borrowing capacity.
- The Company adopted CECL on January 1, 2023, recording a $2.1 million after-tax reduction to retained earnings, including a $1.9 million increase in the loan allowance and a $960,000 allowance for unfunded commitments.
- Nonperforming loans declined to $16.1 million from $21.7 million at December 31, 2022. No loans were charged off during the quarter.
Guidance, Outlook, Risks, Contingencies, and Unusual Items
The filing does not provide quantitative earnings or revenue guidance. Management remains focused on organic growth in customers, loans, deposits and revenue while managing expenses, capital, liquidity and risk.
- Management identifies higher interest rates, inflation, economic contraction, real-estate-market volatility, regional concentration, funding costs and reduced deposit availability as material risks. The Federal Reserve raised the federal funds target rate by 25 basis points during the first quarter and could make further changes.
- The Bank serves cannabis-related customers even though cannabis remains illegal under federal law. Cannabis-related deposits were approximately $123.5 million, or 8.4% of total deposits, and cannabis-related loans were $18.8 million at March 31, 2023.
- An armored-car provider reported that cash stored for cannabis-related customers was missing. The last reported balance was $9.5 million. The Company stated that the potential loss and recoveries cannot yet be determined and that it is pursuing law-enforcement, judicial and insurance remedies. No loss was recorded because the amount was not yet probable and estimable.
- The Company is defending litigation related to the Absecon Gardens condominium project, with claimed damages of approximately $1.7 million. The matter is in early discovery, and the outcome cannot currently be predicted.
- Unused commitments to extend credit were approximately $133.9 million, and standby letters of credit were $1.5 million. The allowance for off-balance-sheet credit exposures was $760,000.
- Unrealized losses on securities totaled $2.1 million at March 31, 2023. Management attributed the losses primarily to interest-rate changes rather than credit deterioration and stated that it does not expect to sell the securities before recovery of amortized cost.
- The Company and Bank were both considered well capitalized. Tier 1 leverage ratios were 14.66% for the Company and 16.15% for Parke Bank.
Important Facts for Investors to Verify
- Whether deposit outflows, particularly from cannabis-related and other noninterest-bearing accounts, continue and require additional wholesale borrowings.
- Whether higher funding costs compress the net interest margin despite loan growth and higher loan yields.
- Future credit performance in the commercial real-estate, construction and residential-investment portfolios, including the $16.1 million of nonperforming loans.
- The final financial impact, if any, of the reported $9.5 million armored-car cash shortfall and potential insurance or other recoveries.
- Whether CECL estimates remain adequate as economic conditions, interest rates and regional real-estate values change.
- The outcome and potential exposure from the Absecon Gardens litigation and any regulatory restrictions referenced in the filing’s risk disclosures.